Hepatic resection for bilobar multicentric hepatocellular carcinoma: Is it justified?

被引:35
作者
Wu, CC
Ho, WL
Lin, MC
Yeh, DC
Wu, HS
Hwang, CJ
Liu, TJ
P'eng, FK
机构
[1] Taichung Vet Gen Hosp, Dept Surg, Taichung, Taiwan
[2] Taichung Vet Gen Hosp, Dept Pathol, Taichung, Taiwan
[3] Natl Yang Ming Med Coll, Dept Surg, Taipei 11221, Taiwan
关键词
D O I
10.1067/msy.1998.85941
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Hepatic resection for multiple hepatocellular carcinomas (HCCs) involving both lobes of the liver is rarely recommended because of high operative risks and low radicality. Thus the justification of hepatic resection for bilobar multicentric HCC remains undefined. Methods. Two hundred eleven patients with HCC, who underwent curative hepatic resection, were studied retrospectively. The patients were divided into two groups. Group A consisted of 39 patients with bilobar (both sides of Cantlie's line) multicentric HCCs. Group B consisted of 172 patients with HCC with solitary or unilobar lesions. The backgrounds and resectional results of patients in groups A and B were compared. Results, Patients in group A usually required multiple separate liver resections and a longer operative time. However, the operative blood loss, amount of blood transfused, and operative morbidity and mortality rates were not significantly different. Patients in group ri showed higher incidences of associated satellite nodules, microscopic vascular Invasion, and a lack of capsules. The 6-year disease-free and actuarial survival rates of patients in groups A and B were 30.5% and 41.8% (P = 0.17) and 42.9% and 51.4% (p = 0.12), respectively. For patients in group A the presence of satellite nodules in any resected tumor was the only independent unfavourable feature that influenced the actuarial survival rate after multivariate analysis. Conclusions. Liver resection is justified for bilobar multicentric HCCs in selected patients, if the tumors can be totally resected. Postoperative adjuvant therapies should be considered when satellite nodules are present in any resected tumor.
引用
收藏
页码:270 / 277
页数:8
相关论文
共 25 条
[1]  
[Anonymous], INT HISTOLOGICAL CLA
[2]   INTRAHEPATIC RECURRENCE AFTER RESECTION OF HEPATOCELLULAR-CARCINOMA COMPLICATING CIRRHOSIS [J].
BELGHITI, J ;
PANIS, Y ;
FARGES, O ;
BENHAMOU, JP ;
FEKETE, F .
ANNALS OF SURGERY, 1991, 214 (02) :114-117
[3]   LIVER RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS [J].
BISMUTH, H ;
CHICHE, L ;
ADAM, R ;
CASTAING, D ;
DIAMOND, T ;
DENNISON, A .
ANNALS OF SURGERY, 1993, 218 (02) :145-151
[4]  
CHILD CG, 1964, LIVER PORTAL HYPERTE, P1
[5]  
COUINAUD C, 1954, PRESSE MED, V62, P709
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]  
HERMANEK P, 1992, INT UNION CANC TNM C, P59
[8]  
HSU HC, 1991, HEPATOLOGY, V13, P923, DOI 10.1002/hep.1840130520
[9]  
KOSUGE T, 1993, HEPATO-GASTROENTEROL, V40, P328
[10]  
KUMADA K, 1990, SURGERY, V108, P821